Suchergebnisse - "Daratumumab"

PubPharm (302)

1

CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Sharma, A. | Gupta, K. | Mishra, A. | +9

UpdateOf: bioRxiv. 2023 Oct 31;:. - PMID 37214794

2

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

3

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

enthalten in: Cancer biology & therapy | 2024

von Wang, H. | Koob, T. | Fromm, J. | +3

4

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes : resetting synergistic activity

enthalten in: Blood cancer journal | 2024

von Kostopoulos, I. | Fotiou, D. | Gavriatopoulou, M. | +14

5

Daratumumab for patients with myeloma with early or late relapse after initial therapy : subgroup analysis of CASTOR and POLLUX

enthalten in: Blood advances | 2024

von Spencer, A. | Moreau, P. | Mateos, M. | +17

6

Improved efficiency of daratumumab treatment of multiple myeloma adopting the subcutaneous route : A micro-costing analysis in three Italian hematology centers

enthalten in: Cancer medicine | 2023

von Pradelli, L. | Massaia, M. | Todisco, E. | +9

7

Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Lonial, S. | Bowser, A. | Chari, A. | +3

8

CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies

enthalten in: Blood advances | 2023

von Perez de Acha, O. | Reiman, L. | Jayabalan, D. | +11

9

Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma

enthalten in: Blood advances | 2023

von Derman, B. | Zonder, J. | Reece, D. | +8

10

Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma

enthalten in: Cancer medicine | 2023

von Bisht, K. | Fukao, T. | Chiron, M. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]